Annual Cash & Cash Equivalents
$46.37 M
-$58.69 M-55.86%
30 June 2022
Summary:
Applied Genetic Technologies annual cash & cash equivalents is currently $46.37 million, with the most recent change of -$58.69 million (-55.86%) on 30 June 2022. During the last 3 years, it has fallen by -$58.69 million (-55.86%).AGTC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$34.24 M
-$12.13 M-26.15%
30 September 2022
Summary:
Applied Genetic Technologies quarterly cash and cash equivalents is currently $34.24 million, with the most recent change of -$12.13 million (-26.15%) on 30 September 2022.AGTC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGTC Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -55.9% | -62.2% |
| 5 y5 years | +73.6% | +110.4% |
AGTC Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -55.9% | -75.6% |
Applied Genetic Technologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $34.24 M(-26.2%) |
| June 2022 | $46.37 M(-55.9%) | $46.37 M(-31.7%) |
| Mar 2022 | - | $67.85 M(-6.8%) |
| Dec 2021 | - | $72.77 M(-19.6%) |
| Sept 2021 | - | $90.52 M(-13.8%) |
| June 2021 | $105.05 M(+173.1%) | $105.05 M(+17.3%) |
| Mar 2021 | - | $89.53 M(+368.6%) |
| Dec 2020 | - | $19.11 M(-39.5%) |
| Sept 2020 | - | $31.57 M(-17.9%) |
| June 2020 | $38.46 M(+44.0%) | $38.46 M(-34.2%) |
| Mar 2020 | - | $58.49 M(+223.6%) |
| Dec 2019 | - | $18.08 M(+11.1%) |
| Sept 2019 | - | $16.27 M(-39.1%) |
| June 2019 | $26.70 M(-14.0%) | $26.70 M(+23.8%) |
| Mar 2019 | - | $21.57 M(-10.0%) |
| Dec 2018 | - | $23.98 M(-9.4%) |
| Sept 2018 | - | $26.47 M(-14.8%) |
| June 2018 | $31.07 M | $31.07 M(-34.8%) |
| Mar 2018 | - | $47.63 M(-32.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | - | $70.34 M(+44.3%) |
| Sept 2017 | - | $48.73 M(+58.7%) |
| June 2017 | $30.71 M(+6.4%) | $30.71 M(-13.5%) |
| Mar 2017 | - | $35.50 M(-16.5%) |
| Dec 2016 | - | $42.50 M(-24.1%) |
| Sept 2016 | - | $55.98 M(+93.9%) |
| June 2016 | $28.87 M(-26.3%) | $28.87 M(+61.4%) |
| Mar 2016 | - | $17.88 M(-59.7%) |
| Dec 2015 | - | $44.40 M(-68.3%) |
| Sept 2015 | - | $140.26 M(+257.9%) |
| June 2015 | $39.19 M(+354.4%) | $39.19 M(-11.9%) |
| Mar 2015 | - | $44.48 M(+0.6%) |
| Dec 2014 | - | $44.23 M(-5.6%) |
| Sept 2014 | - | $46.84 M(+443.2%) |
| June 2014 | $8.62 M(-3.0%) | $8.62 M(+7.4%) |
| Mar 2014 | - | $8.03 M(-10.8%) |
| Dec 2013 | - | $9.00 M(+14.5%) |
| Sept 2013 | - | $7.86 M(-11.6%) |
| June 2013 | $8.89 M(+1049.0%) | $8.89 M |
| June 2012 | $774.00 K | - |
FAQ
- What is Applied Genetic Technologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Applied Genetic Technologies?
- What is Applied Genetic Technologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Applied Genetic Technologies?
What is Applied Genetic Technologies annual cash & cash equivalents?
The current annual cash & cash equivalents of AGTC is $46.37 M
What is the all time high annual cash & cash equivalents for Applied Genetic Technologies?
Applied Genetic Technologies all-time high annual cash & cash equivalents is $105.05 M
What is Applied Genetic Technologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AGTC is $34.24 M
What is the all time high quarterly cash and cash equivalents for Applied Genetic Technologies?
Applied Genetic Technologies all-time high quarterly cash and cash equivalents is $140.26 M